| Product Code: ETC13139699 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Monkeypox Market was valued at USD 0.7 Billion in 2024 and is expected to reach USD 1.3 Billion by 2031, growing at a compound annual growth rate of 7.90% during the forecast period (2025-2031).
The global monkeypox market is characterized by ongoing research and development efforts to better understand and combat this rare viral disease. Monkeypox, a zoonotic disease with symptoms similar to smallpox, remains a public health concern primarily in Central and West Africa. The market for monkeypox treatment and prevention includes antiviral medications, vaccines, and supportive care options. Research initiatives focus on improving diagnostics, developing effective treatments, and enhancing prevention strategies, given the potential for outbreaks and international spread. Collaboration between healthcare organizations, pharmaceutical companies, and government agencies is essential in addressing the challenges posed by monkeypox, with a concerted effort towards enhancing global preparedness and response capabilities in the face of emerging infectious diseases.
The global monkeypox market is witnessing a growing focus on research and development for new treatment options and vaccines, driven by the increasing prevalence of monkeypox cases across various regions. With a rising awareness about zoonotic diseases and the potential threat of monkeypox outbreaks, there is a significant opportunity for pharmaceutical companies to invest in the development of effective therapeutics and preventive measures. Moreover, collaborations between government agencies, research institutions, and pharmaceutical companies are fostering innovation in the field. The market is also seeing a surge in funding for monkeypox research, creating opportunities for advancements in diagnostics and treatment strategies. Overall, the global monkeypox market presents promising prospects for stakeholders to address the unmet medical needs related to this emerging infectious disease.
The Global Monkeypox Market faces several challenges, including limited awareness about the disease among healthcare professionals and the general public, leading to delayed diagnosis and treatment. The similarity of early symptoms to other common illnesses like chickenpox and smallpox also poses a challenge in accurate diagnosis. Additionally, the lack of specific antiviral treatments or vaccines for monkeypox makes managing the disease difficult, leading to a reliance on supportive care measures. Limited funding for research and development, as well as the sporadic nature of outbreaks, hinder efforts to develop effective interventions. Furthermore, the zoonotic nature of monkeypox, with animals serving as reservoirs for the virus, adds complexity to prevention and control measures. Overall, addressing these challenges will be crucial in effectively managing and controlling monkeypox in the global market.
The global monkeypox market is primarily driven by factors such as increasing research and development activities for the development of effective treatments and vaccines, rising prevalence of monkeypox cases in regions like Africa and parts of the Americas, and growing awareness about the disease among healthcare professionals and the general population. Additionally, government initiatives and funding to combat infectious diseases, advancements in diagnostic technologies, and collaborations between pharmaceutical companies and research institutions are also contributing to the growth of the monkeypox market. The potential for outbreaks and the need for effective control measures further underscore the significance of investments and efforts in this market.
Government policies related to the Global Monkeypox Market primarily focus on surveillance, control, and prevention measures to limit the spread of the disease. These policies typically involve strict monitoring of potential outbreaks, rapid response strategies to contain the virus, and vaccination campaigns in at-risk regions. Additionally, governments may implement import/export restrictions on wildlife species known to carry the virus, along with regulations on the transportation and handling of animals to reduce the risk of transmission to humans. Some countries also enforce quarantine protocols for individuals suspected of being infected with monkeypox to prevent further dissemination. Overall, these government policies aim to safeguard public health and prevent the escalation of monkeypox cases on a global scale.
The Global Monkeypox Market is expected to witness significant growth in the coming years due to increasing awareness, research and development activities, and rising incidences of monkeypox cases globally. The market is likely to be driven by the development of novel treatments, diagnostics, and vaccines for monkeypox, as well as the growing demand for effective healthcare solutions. Additionally, government initiatives and collaborations between pharmaceutical companies and research institutions are anticipated to further propel market growth. However, challenges such as regulatory hurdles, limited healthcare infrastructure in some regions, and the high cost of treatments may hinder market expansion. Overall, the Global Monkeypox Market is poised for growth, with opportunities for innovation and investment in the coming years.
In the global Monkeypox market, North America is expected to lead in terms of market share due to the presence of advanced healthcare infrastructure and high awareness levels. Europe is also anticipated to witness significant growth, attributed to the increasing research and development activities in the region. The Asia Pacific region is projected to emerge as a lucrative market for Monkeypox treatment, driven by the rising incidence of the disease and improving healthcare facilities. The Middle East and Africa are likely to show moderate growth, mainly due to the limited awareness and resources for treating Monkeypox. Latin America is expected to witness steady growth, supported by government initiatives to improve healthcare access and increasing investments in healthcare infrastructure. Overall, the global Monkeypox market is poised for growth across all regions, with varying levels of opportunities and challenges present in each geographic area.
Global Monkeypox Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Monkeypox Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Monkeypox Market Revenues & Volume, 2021 & 2031F |
3.3 Global Monkeypox Market - Industry Life Cycle |
3.4 Global Monkeypox Market - Porter's Five Forces |
3.5 Global Monkeypox Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Monkeypox Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Global Monkeypox Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.8 Global Monkeypox Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Monkeypox Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Monkeypox Market Trends |
6 Global Monkeypox Market, 2021 - 2031 |
6.1 Global Monkeypox Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Monkeypox Market, Revenues & Volume, By Cidofovir, 2021 - 2031 |
6.1.3 Global Monkeypox Market, Revenues & Volume, By Brincidofovir, 2021 - 2031 |
6.1.4 Global Monkeypox Market, Revenues & Volume, By Tecovirimat, 2021 - 2031 |
6.1.5 Global Monkeypox Market, Revenues & Volume, By Vaccinia ImmuneGlobulin, 2021 - 2031 |
6.2 Global Monkeypox Market, Revenues & Volume, By End users, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Monkeypox Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.2.3 Global Monkeypox Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.2.4 Global Monkeypox Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Monkeypox Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Monkeypox Market, Revenues & Volume, By Direct Tender, 2021 - 2031 |
6.3.3 Global Monkeypox Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.3.4 Global Monkeypox Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.3.5 Global Monkeypox Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.3.6 Global Monkeypox Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Monkeypox Market, Overview & Analysis |
7.1 North America Monkeypox Market Revenues & Volume, 2021 - 2031 |
7.2 North America Monkeypox Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Monkeypox Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Monkeypox Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Monkeypox Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Monkeypox Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Monkeypox Market, Revenues & Volume, By End users, 2021 - 2031 |
7.5 North America Monkeypox Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Monkeypox Market, Overview & Analysis |
8.1 Latin America (LATAM) Monkeypox Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Monkeypox Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Monkeypox Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Monkeypox Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Monkeypox Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Monkeypox Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Monkeypox Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.4 Latin America (LATAM) Monkeypox Market, Revenues & Volume, By End users, 2021 - 2031 |
8.5 Latin America (LATAM) Monkeypox Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Monkeypox Market, Overview & Analysis |
9.1 Asia Monkeypox Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Monkeypox Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Monkeypox Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Monkeypox Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Monkeypox Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Monkeypox Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Monkeypox Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.4 Asia Monkeypox Market, Revenues & Volume, By End users, 2021 - 2031 |
9.5 Asia Monkeypox Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Monkeypox Market, Overview & Analysis |
10.1 Africa Monkeypox Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Monkeypox Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Monkeypox Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Monkeypox Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Monkeypox Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Monkeypox Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Monkeypox Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.4 Africa Monkeypox Market, Revenues & Volume, By End users, 2021 - 2031 |
10.5 Africa Monkeypox Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Monkeypox Market, Overview & Analysis |
11.1 Europe Monkeypox Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Monkeypox Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Monkeypox Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Monkeypox Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Monkeypox Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Monkeypox Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Monkeypox Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.4 Europe Monkeypox Market, Revenues & Volume, By End users, 2021 - 2031 |
11.5 Europe Monkeypox Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Monkeypox Market, Overview & Analysis |
12.1 Middle East Monkeypox Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Monkeypox Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Monkeypox Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Monkeypox Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Monkeypox Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Monkeypox Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.4 Middle East Monkeypox Market, Revenues & Volume, By End users, 2021 - 2031 |
12.5 Middle East Monkeypox Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Monkeypox Market Key Performance Indicators |
14 Global Monkeypox Market - Export/Import By Countries Assessment |
15 Global Monkeypox Market - Opportunity Assessment |
15.1 Global Monkeypox Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Monkeypox Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.3 Global Monkeypox Market Opportunity Assessment, By End users, 2021 & 2031F |
15.4 Global Monkeypox Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Monkeypox Market - Competitive Landscape |
16.1 Global Monkeypox Market Revenue Share, By Companies, 2024 |
16.2 Global Monkeypox Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |